focus -WSS

focus

author：Wikipedia 2025-09-06 20:46:22 - browse：6571

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Medicare Advantage's lean provider networks lead CMS complaints

entertainment

WSS

Illumina board agrees to spin off Grail, as divestment plans proceed

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Anthony Fauci pushes back on GOP claims during Covid hearing

How CO2 helps viruses stay alive longer in the air

Connecting traumatic brain injury and domestic violence

Connecting traumatic brain injury and domestic violence

explore

focus

entertainment

How to save PrEP access — and even expand it

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Jerome Adams on the need for new antivirals for Covid

FTC loses bid to block Novant's North Carolina hospital merger

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare Advantage's lean provider networks lead CMS complaints

Psychedelics group wrestles with new pharma identity

Make 'food is medicine' a key part of White House nutrition meeting

Tori Bowie and the unacceptable rates of Black maternal death

Make 'food is medicine' a key part of White House nutrition meeting

leisure time

Illumina board agrees to spin off Grail, as divestment plans proceed

Grail is spending more than ever lobbying Congress

Data don't support strong claims for Covid

Senators tussle over abortion against the backdrop of a presidential campaign

Australia's humpback populations rebound raising hopes of marine scientists

Pfizer's Covid pill remains 89% effective in final analysis, company says

focus

focus

entertainment

leisure time